The oral administration of Δ9-tetrahydrocannabinol (THC) may treat both spasticity and pain associated with multiple sclerosis. This is according to a study being published by the journal Clinical Therapeutics, and e-published ahead of print by the U.S. National Institute of Health. According to the Mayo Clinic, multiple sclerosis (MS) is a “disease in which the …
Tag: Multiple Sclerosis treatment
- clinical therapeutics, Mayo Clinic, ms, ms cannabis, ms marijuana, ms treatment, ms weed, multiple sclerosis, Multiple Sclerosis cannabis, Multiple Sclerosis marijuana, Multiple Sclerosis treatment, Multiple Sclerosis weed, national institute of health, spasticity, Spasticity cannabis, Spasticity marijuana, Spasticity treatment, Spasticity weed
- How Cannabis Can Help Seniors Improve Their Quality Of Life
- Study: Strong Majority of Hospice Professionals Support Medical Marijuana
- What is CBD Microdosing?
- New Mexico Adds Opioid Use Disorder and Other Ailments as Qualifying Medical Marijuana Condition
- Presence Of THC In Blood is Not Associated With Crash Culpability, Finds Study
- Study: Medical Marijuana Legalization Associated With Lower Opioid Prescription Rates
- Illinois Senate Approves Bill to Legalize Marijuana
- Why Treating Epileptic Seizures With CBD Oil Is A Good Idea?
Thank you for reading TheJointBlog.com!